# Safety and Efficacy Study of Gynevac Lactobacillus Vaccine in the Treatment of Bacterial Vaginosis

> **NCT02173184** · PHASE3 · UNKNOWN · sponsor: **Amvac Kft.** · enrollment: 240 (estimated)

## Conditions studied

- Bacterial Vaginosis

## Interventions

- **BIOLOGICAL:** Gynevac
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02173184
- **Lead sponsor:** Amvac Kft.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06
- **Primary completion:** 2015-04
- **Final completion:** 2015-07
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2014-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02173184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02173184, "Safety and Efficacy Study of Gynevac Lactobacillus Vaccine in the Treatment of Bacterial Vaginosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02173184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*